Home Page ::: Clinical Cancer Drugs

ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)


Volume 1, 2 Issues, 2014






Clinical Cancer Drugs

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Yuval Shaked


Department of Molecular Pharmacology Rappaport Faculty of Medicine, Technion - Israel Institute of Technology
Haifa
Israel


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Forthcoming Special Issue(s)

THE CHANGING LANDSCAPE OF MELANOMA TREATMENT


Guest Editor(s): Matias E. Valsecchi
Tentative Publish Date: June, 2014
Submit Abstract via Email Download Description
Authors' Comments
It is my immense pleasure to be one of the authors of Bentham Science Publishers. As an author, I am extremely happy to share my feedback. My article was published in “Current Computer-Aided Drug Design”.
I found the quality, services and support at BSP quite excellent. I have also come to learn that Bentham journals have a very high standard and they always try to maintain it. I am also pleased with their quick response and timely updates. I am thanking all the reviewers for their precious time and critical suggestions.
I also thank the editorial board and the publishing staff for their support and guidance. I would like to thank the Editor-in-Chief, Dr. Subhash Basak and other editorial members for their valuable suggestions, guidance and feedback.
I am very much honored to be an author in Bentham Science Publishers.

Dr. Sinosh Skariyachan
Has contributed: Molecular Modeling on Streptolysin-O of Multidrug Resistant Streptococcus Pyogenes and Computer Aided Screening and In Vitro Assay for Novel Herbal Inhibitors
Advertisement

Related Journals




Related eBooks




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science